General Information of Drug (ID: DMEKU71)

Drug Name
Dodeca-2E,4E-dienoic acid isobutylamide Drug Info
Synonyms
UNII-5F4WO3BVS9; dodeca-2E,4E-dienoic acid isobutylamide; N-isobutyl-(2E,4E)-dodecadienamide; N-Isobutyldodeca-trans-2,4-dienamide; 5F4WO3BVS9; CHEMBL426912; CHEBI:70101; 2,4-Dodecadienamide, N-(2-methylpropyl)-, (2E,4E)-; Kalecide; Dodecatetraenoic acid isobutylamide, (2E,4E)-; AC1O5Y9Z; (2E,4E)-N-(2-methylpropyl)dodeca-2,4-dienamide; SCHEMBL2262688; MolPort-005-944-951; BBRMJCAPNGJKEM-AQASXUMVSA-N; BDBM50212599; ZINC36294914; 2,4-(E,E)-Dodecadienoylisobutylamide; MCULE-7934862818; (E,E)-N-Isobutyl-2,4-dodecadienamide
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
6443006
ChEBI ID
CHEBI:70101
CAS Number
CAS 24738-51-0
TTD Drug ID
DMEKU71

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cannabinoid receptor 2 (CB2) TTMSFAW CNR2_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Cannabinoid receptor 2 (CB2) DTT CNR2 7.037 6.733 6.944 7.163
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Cannabinoid receptor 2 (CB2) DTT CNR2 3.82E-02 -0.43 -1.18
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Self-assembling cannabinomimetics: supramolecular structures of N-alkyl amides. J Nat Prod. 2007 Jun;70(6):1010-5.